Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02836886 · ClinicalTrials.gov registry record
VircapSeq Virus Detection in Sézary Syndrome
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 6
- Enrollment target
NCT02836886 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 6 participants.
The verdict
NCT02836886 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
Study Summary
This study will be using this technique, called "VirCapSeq-VERT" to analyze the white blood cells of patients with Sézary syndrome. This could provide the foundation for future studies looking to understand the role that viruses play in the origin of Sézary syndrome. This could have important implications for the future development of new and effective therapies for the disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-06 |
| Est. Completion | 2016-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02836886
The ClinicalTrials.gov registry entry for NCT02836886 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02836886 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02836886 about?
NCT02836886 is a clinical study titled "VircapSeq Virus Detection in Sézary Syndrome". This study will be using this technique, called "VirCapSeq-VERT" to analyze the white blood cells of patients with Sézary syndrome. This could provide the foundation for future studies looking to understand the role that viruses play in the origin of Sézary syndrome. This could have important implic...
What is the current status of trial NCT02836886?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2016-06. Estimated completion is 2016-10.
Who is sponsoring clinical trial NCT02836886?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.